The trademark application ZENGINE was filed by Zelluna Immunotherapy AS, a corporation established under the laws of the Kingdom of Norway (the "Applicant"). The application was published for oppositions on August 1, 2023, and it was registered by office on November 8, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 30, 2023.
Goods And Services
The mark was filed in class 42 with following description of goods:
Providing technology platforms
Providing technology for use in medical field
Providing technology platforms for discovery and optimization of T cell receptors for use in cellular therapies for treatment of solid cancers
Biological research
Biological analysis
Biological research laboratory services
Services of a chemical and/or biological laboratory
Scientific services
Scientific advisory services
Scientific research and analysis
Design services relating to the T cell receptors
Scientific services relating to the T cell receptors for use in cellular therapies for treatment of solid cancers.